查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1755959

2032 年蛋白质工程市场预测：按产品、类型、技术、应用、最终用户和地区进行的全球分析

Protein Engineering Market Forecasts to 2032 - Global Analysis By Product (Instruments, Consumables and Software & Services), Type, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球蛋白质工程市场预计在 2025 年达到 35 亿美元，到 2032 年将达到 86 亿美元，预测期内的复合年增长率为 16.2%。

蛋白质工程是指透过设计和改造蛋白质来增强或创造特定功能。科学家利用定向进化和理性设计等技术改变蛋白质的结构，以提高稳定性、活性和特异性。其应用包括开发用于工业生产的酵素、用于治疗的抗体以及诊断蛋白。它结合分子生物学、计算建模和生物化学，以客製化蛋白质用于生物或工业用途。

扩大工业酵素的用途

生物技术和製药业对高效能工业酵素的需求日益增长，推动了蛋白质工程市场的发展。这些酵素可以增强药物製造和生质燃料生产等製程。对永续且经济高效的工业解决方案的需求也推动了市场的成长。基因工程技术的进步使得高性能酵素的设计成为可能。日益增长的生物加工应用也支持了市场的扩张。在产业需求的推动下，蛋白质工程正在经历显着的成长。

研发成本高

蛋白质工程需要大量的研究投入，包括先进的计算工具和实验设备。设计新型蛋白质的复杂性增加了开发成本。小型生物技术公司在进行创新计划时往往面临资金限制。蛋白质优化需要时间，这增加了成本。高昂的成本可能会延迟新解决方案的市场准入。经济壁垒是一项挑战，研发成本也阻碍了市场成长。

新型生技药品的开发

单株抗体和基因治疗药物等新型生技药品的开发为蛋白质工程提供了重大机会。这些生技药品解决了癌症和罕见疾病等领域尚未满足的医疗需求。蛋白质设计技术的进步提高了生技药品的疗效和特异性。个人化医疗投资的不断增加推动了对重组蛋白的需求。突破性治疗方法的潜力增强了市场乐观情绪。在医疗创新的推动下，新型生技药品有望显着成长。

智慧财产纠纷

蛋白质工程技术的智慧财产权纠纷可能阻碍市场成长。生技公司之间的专利纠纷可能会延迟产品开发和商业化。蛋白质工程领域的专利格局复杂，导致法律不确定性。高昂的诉讼成本可能会使中小企业的管理资源紧张。专有技术纠纷扰乱市场稳定。受法律挑战的影响，智慧财产权纠纷威胁着市场的永续发展。

COVID-19的影响：

新冠疫情加速了疫苗和疗法研发领域对蛋白质工程的需求。然而，研究活动和供应链的中断导致非新冠疫情计划出现延误。快速疫苗研发的重点凸显了工程蛋白质的重要性。疫情期间，预算重新分配限制了其他蛋白质工程倡议的资金。疫情后的復苏刺激了对生技药品和工业酵素的投资。在医疗保健重点的推动下，市场正在復苏，并重新聚焦。

预计设备部分将成为预测期内最大的部分

由于先进工具在蛋白质设计和分析中发挥着至关重要的作用，预计仪器仪表领域将在预测期内占据最大的市场占有率份额。高通量筛检系统和运算平台正在推动对专用仪器仪表的需求。蛋白质工程计划日益复杂，也推动了它们的应用。这些仪器仪表能够实现工业和医疗应用中的精确蛋白质修饰。生物技术研发投入的不断增加也进一步推动了市场的成长。由于技术进步，仪器仪表领域预计将占据最大的市场占有率。

预计预测期内单株抗体部分将以最高的复合年增长率成长。

在预测期内，单株抗体领域预计将实现最高成长率，这得益于其在癌症和自体免疫疾病标靶治疗中的关键作用。蛋白质工程的进步提高了抗体的特异性和治疗效果。慢性病的增加推动了对单株抗体的需求。对下一代生技药品的持续研究将推动市场扩张。对个人化医疗的关注将加速其应用。在医学突破的推动下，该领域将实现最高成长率。

占比最大的地区：

在预测期内，由于生物技术和製药行业的成长，预计亚太地区将占据最大的市场占有率。中国和印度等国家正大力投资生物加工和生技药品开发。该地区对可负担医疗保健解决方案的重视推动了对工程蛋白质的需求。政府对生物技术创新的支持将促进市场成长。快速的工业化将进一步巩固市场地位。在强劲的生物技术成长的支持下，亚太地区正引领全球市场。

复合年增长率最高的地区：

在预测期内，由于先进的科研基础设施和生物技术创新，北美预计将实现最高的复合年增长率。该地区对个人化医疗和新型生技药品的关注正在推动需求成长。大型製药企业对研发的巨额投资正在推动市场扩张。领先生物技术公司的存在正在推动市场成长。对创新治疗方法的监管支持巩固了该地区的地位。在尖端研究的推动下，北美市场将快速成长。

免费客製化服务

订阅此报告的客户可享有以下免费自订选项之一：

  • 公司简介
    • 全面分析其他市场参与者（最多 3 家公司）
    • 主要企业的SWOT分析（最多3家公司）
  • 地理细分
    • 根据客户兴趣对主要国家市场进行估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 研究范围
  • 调查方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 研究途径
  • 研究材料
    • 主要研究资料
    • 次级研究资讯来源
    • 先决条件

第三章市场走势分析

  • 驱动程式
  • 限制因素
  • 机会
  • 威胁
  • 产品分析
  • 技术分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买家的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球蛋白质工程市场（按产品）

  • 装置
  • 耗材
  • 软体和服务

6. 全球蛋白质工程市场（按类型）

  • 单株抗体
  • 促红血球生成素
  • 干扰素
  • 疫苗
  • 集落刺激因子
  • 生长激素
  • 凝血因子
  • 其他类型

7. 全球蛋白质工程市场（按技术）

  • 合理蛋白质设计
  • 不合理的蛋白质设计

8. 全球蛋白质工程市场（按应用）

  • 药物研发
  • 治疗应用
  • 工业酵素开发
  • 诊断
  • 其他用途

9. 全球蛋白质工程市场（依最终用户）

  • 生物製药公司
  • 受託研究机构
  • 学术研究所

第十章全球蛋白质工程市场（按地区）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十一章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十二章 公司概况

  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Merck KGaA
  • Bruker Corporation
  • Waters Corporation
  • PerkinElmer, Inc.
  • Amgen Inc.
  • Eli Lilly and Company
  • Genentech, Inc.
  • Codexis, Inc.
  • Genscript Biotech Corporation
  • Integrated DNA Technologies, Inc.
  • Novo Nordisk A/S
  • Sanofi SA
  • Johnson & Johnson
  • Vertex Pharmaceuticals Incorporated
  • Lonza Group
  • Kyowa Kirin Co., Ltd.
Product Code: SMRC29853

According to Stratistics MRC, the Global Protein Engineering Market is accounted for $3.5 billion in 2025 and is expected to reach $8.6 billion by 2032 growing at a CAGR of 16.2% during the forecast period. Protein engineering is the design and modification of proteins to enhance or create specific functions. Using techniques like directed evolution and rational design, scientists alter protein structures to improve stability, activity, or specificity. Applications include developing enzymes for industrial processes, antibodies for therapeutics, and proteins for diagnostics. It combines molecular biology, computational modeling, and biochemistry to tailor proteins for targeted biological or industrial purposes.

Market Dynamics:

Driver:

Increased use in industrial enzymes

The growing demand for efficient industrial enzymes in biotechnology and pharmaceuticals drives the protein engineering market. These enzymes enhance processes like drug manufacturing and biofuel production. The need for sustainable and cost-effective industrial solutions fuels market growth. Advances in genetic engineering techniques enable the design of high-performance enzymes. The rise in bioprocessing applications supports market expansion. Fueled by industrial needs, protein engineering is experiencing significant growth.

Restraint:

High R&D costs

Protein engineering requires substantial investment in research, including advanced computational tools and laboratory equipment. The complexity of designing novel proteins increases development costs. Small biotech firms often face financial constraints in pursuing innovative projects. The lengthy process of protein optimization adds to the expense. High costs can delay market entry for new solutions. Triggered by financial barriers, R&D costs challenge market growth.

Opportunity:

Development of novel biologics

The development of novel biologics, such as monoclonal antibodies and gene therapies, presents significant opportunities for protein engineering. These biologics address unmet medical needs in areas like cancer and rare diseases. Advances in protein design techniques enhance the efficacy and specificity of biologics. Growing investments in personalized medicine drive demand for engineered proteins. The potential for breakthrough therapies fuels market optimism. Spurred by medical innovations, novel biologics offer substantial growth prospects.

Threat:

Intellectual property disputes

Intellectual property disputes over protein engineering technologies can hinder market growth. Patent conflicts among biotech firms may delay product development and commercialization. The complexity of patent landscapes in protein engineering creates legal uncertainties. High litigation costs can strain resources for smaller companies. Disputes over proprietary techniques disrupt market stability. Influenced by legal challenges, IP disputes threaten sustained market progress.

Covid-19 Impact:

The COVID-19 pandemic accelerated demand for protein engineering in vaccine and therapeutic development. However, disruptions in research activities and supply chains delayed non-COVID projects. The focus on rapid vaccine development highlighted the importance of engineered proteins. Budget reallocations limited funding for other protein engineering initiatives during the crisis. The post-pandemic recovery has spurred investments in biologics and industrial enzymes. Guided by healthcare priorities, the market is rebounding with renewed focus.

The instruments segment is expected to be the largest during the forecast period

The instruments segment is expected to account for the largest market share during the forecast period, due to the critical role of advanced tools in protein design and analysis. High-throughput screening systems and computational platforms drive demand for specialized instruments. The growing complexity of protein engineering projects fuels their adoption. These instruments enable precise protein modification for industrial and medical applications. Rising investments in biotech R&D further support market growth. Powered by technological advancements, the instruments segment holds the largest market share.

The monoclonal antibodies segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the monoclonal antibodies segment is predicted to witness the highest growth rate, due to their critical role in targeted therapies for cancer and autoimmune diseases. Advances in protein engineering enhance their specificity and therapeutic efficacy. The rising prevalence of chronic diseases drives demand for monoclonal antibodies. Ongoing research into next-generation biologics fuels market expansion. The focus on personalized medicine accelerates its adoption. Propelled by medical breakthroughs, this segment is set for the highest growth rate.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share, due to its growing biotechnology and pharmaceutical industries. Countries like China and India are investing heavily in bioprocessing and biologics development. The region's focus on affordable healthcare solutions drives demand for engineered proteins. Government support for biotech innovation bolsters market growth. Rapid industrialization further strengthens the market's position. Backed by robust biotech growth, Asia Pacific leads the global market.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, due to its advanced research infrastructure and biotech innovation. The region's focus on personalized medicine and novel biologics fuels demand. Significant investments in R&D by major pharmaceutical companies drive market expansion. The presence of leading biotech firms enhances market growth. Regulatory support for innovative therapies strengthens the region's position. Motivated by cutting-edge research, North America is poised for rapid market growth.

Key players in the market

Some of the key players in Protein Engineering Market include Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Merck KGaA, Bruker Corporation, Waters Corporation, PerkinElmer, Inc., Amgen Inc., Eli Lilly and Company, Genentech, Inc., Codexis, Inc., Genscript Biotech Corporation, Integrated DNA Technologies, Inc., Novo Nordisk A/S, Sanofi S.A., Johnson & Johnson, Vertex Pharmaceuticals Incorporated, Lonza Group, and Kyowa Kirin Co., Ltd.

Key Developments:

In March 2025, Merck KGaA opened a biologics innovation hub in Asia Pacific, focusing on protein engineering for novel therapeutics. The facility leverages AI and high-throughput screening to develop targeted biologics, addressing unmet medical needs.

In February 2025, Agilent Technologies launched a next-generation protein analysis system for biologics research. Equipped with advanced spectrometry, it supports precise protein modification for industrial and medical applications, enhancing research efficiency and scalability.

Products Covered:

  • Instruments
  • Consumables
  • Software & Services

Types Covered:

  • Monoclonal Antibodies
  • Erythropoietin
  • Interferons
  • Vaccines
  • Colony-stimulating Factors
  • Growth Hormones
  • Coagulation Factors
  • Other Types

Technologies Covered:

  • Rational Protein Design
  • Irrational Protein Design

Applications Covered:

  • Drug Discovery & Development
  • Therapeutic Applications
  • Industrial Enzyme Development
  • Diagnostics
  • Other Applications

End Users Covered:

  • Biopharmaceutical Companies
  • Contract Research Organizations
  • Academic Research Institutes

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Emerging Markets
  • 3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Protein Engineering Market, By Product

  • 5.1 Introduction
  • 5.2 Instruments
  • 5.3 Consumables
  • 5.4 Software & Services

6 Global Protein Engineering Market, By Type

  • 6.1 Introduction
  • 6.2 Monoclonal Antibodies
  • 6.3 Erythropoietin
  • 6.4 Interferons
  • 6.5 Vaccines
  • 6.6 Colony-stimulating Factors
  • 6.7 Growth Hormones
  • 6.8 Coagulation Factors
  • 6.9 Other Types

7 Global Protein Engineering Market, By Technology

  • 7.1 Introduction
  • 7.2 Rational Protein Design
  • 7.3 Irrational Protein Design

8 Global Protein Engineering Market, By Application

  • 8.1 Introduction
  • 8.2 Drug Discovery & Development
  • 8.3 Therapeutic Applications
  • 8.4 Industrial Enzyme Development
  • 8.5 Diagnostics
  • 8.6 Other Applications

9 Global Protein Engineering Market, By End User

  • 9.1 Introduction
  • 9.2 Biopharmaceutical Companies
  • 9.3 Contract Research Organizations
  • 9.4 Academic Research Institutes

10 Global Protein Engineering Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Thermo Fisher Scientific Inc.
  • 12.2 Danaher Corporation
  • 12.3 Agilent Technologies, Inc.
  • 12.4 Bio-Rad Laboratories, Inc.
  • 12.5 Merck KGaA
  • 12.6 Bruker Corporation
  • 12.7 Waters Corporation
  • 12.8 PerkinElmer, Inc.
  • 12.9 Amgen Inc.
  • 12.10 Eli Lilly and Company
  • 12.11 Genentech, Inc.
  • 12.12 Codexis, Inc.
  • 12.13 Genscript Biotech Corporation
  • 12.14 Integrated DNA Technologies, Inc.
  • 12.15 Novo Nordisk A/S
  • 12.16 Sanofi S.A.
  • 12.17 Johnson & Johnson
  • 12.18 Vertex Pharmaceuticals Incorporated
  • 12.19 Lonza Group
  • 12.20 Kyowa Kirin Co., Ltd.

List of Tables

  • Table 1 Global Protein Engineering Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Protein Engineering Market Outlook, By Product (2024-2032) ($MN)
  • Table 3 Global Protein Engineering Market Outlook, By Instruments (2024-2032) ($MN)
  • Table 4 Global Protein Engineering Market Outlook, By Consumables (2024-2032) ($MN)
  • Table 5 Global Protein Engineering Market Outlook, By Software & Services (2024-2032) ($MN)
  • Table 6 Global Protein Engineering Market Outlook, By Type (2024-2032) ($MN)
  • Table 7 Global Protein Engineering Market Outlook, By Monoclonal Antibodies (2024-2032) ($MN)
  • Table 8 Global Protein Engineering Market Outlook, By Erythropoietin (2024-2032) ($MN)
  • Table 9 Global Protein Engineering Market Outlook, By Interferons (2024-2032) ($MN)
  • Table 10 Global Protein Engineering Market Outlook, By Vaccines (2024-2032) ($MN)
  • Table 11 Global Protein Engineering Market Outlook, By Colony-stimulating Factors (2024-2032) ($MN)
  • Table 12 Global Protein Engineering Market Outlook, By Growth Hormones (2024-2032) ($MN)
  • Table 13 Global Protein Engineering Market Outlook, By Coagulation Factors (2024-2032) ($MN)
  • Table 14 Global Protein Engineering Market Outlook, By Other Types (2024-2032) ($MN)
  • Table 15 Global Protein Engineering Market Outlook, By Technology (2024-2032) ($MN)
  • Table 16 Global Protein Engineering Market Outlook, By Rational Protein Design (2024-2032) ($MN)
  • Table 17 Global Protein Engineering Market Outlook, By Irrational Protein Design (2024-2032) ($MN)
  • Table 18 Global Protein Engineering Market Outlook, By Application (2024-2032) ($MN)
  • Table 19 Global Protein Engineering Market Outlook, By Drug Discovery & Development (2024-2032) ($MN)
  • Table 20 Global Protein Engineering Market Outlook, By Therapeutic Applications (2024-2032) ($MN)
  • Table 21 Global Protein Engineering Market Outlook, By Industrial Enzyme Development (2024-2032) ($MN)
  • Table 22 Global Protein Engineering Market Outlook, By Diagnostics (2024-2032) ($MN)
  • Table 23 Global Protein Engineering Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 24 Global Protein Engineering Market Outlook, By End User (2024-2032) ($MN)
  • Table 25 Global Protein Engineering Market Outlook, By Biopharmaceutical Companies (2024-2032) ($MN)
  • Table 26 Global Protein Engineering Market Outlook, By Contract Research Organizations (2024-2032) ($MN)
  • Table 27 Global Protein Engineering Market Outlook, By Academic Research Institutes (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.